mineral exploration project – commodity prices – mining stock- trade and market

For the third quarter, Pfizer’s net income increased to $2.88 billion or $0.43 per share from $2.28 billion or $0.34 per share in the year-ago period, driven by lower one-time charges as well as cost-reduction initiatives. Quarterly revenues dropped 3% to $11.62 billion from $11.97 billion in the comparable quarter last year.